MOYAMOYA DISEASE 6 WITH OR WITHOUT ACHALASIA
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia.
|
24581742 |
2014 |
MOYAMOYA DISEASE 6 WITH OR WITHOUT ACHALASIA
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Moyamoya disease 1
|
0.120 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
|
24213632 |
2013 |
Glioma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Here, we report that 2 of 9 human glioma cell lines, CCF-STTG1 and U-87MG, overproduced cyclic GMP (cGMP) and showed increased expression of both or either subunits of soluble GC1, GUCY1A3 and GUCY1B3.
|
15201957 |
2004 |
MOYAMOYA DISEASE 6 WITH OR WITHOUT ACHALASIA
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
MOYAMOYA DISEASE 6 WITH OR WITHOUT ACHALASIA
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension.
|
26777256 |
2016 |
Coronary Artery Disease
|
0.450 |
Biomarker
|
disease |
CTD_human |
Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease.
|
22751097 |
2012 |
Coronary Artery Disease
|
0.450 |
Biomarker
|
disease |
BEFREE |
GUCY1A3, encoding the α1 subunit, was identified as a risk gene for coronary artery disease and myocardial infarction, but its specific contribution to atherosclerosis remains unclear.
|
27315776 |
2016 |
Hypertensive disease
|
0.430 |
Biomarker
|
group |
CTD_human |
Gender-specific hypertension and responsiveness to nitric oxide in sGCalpha1 knockout mice.
|
18339647 |
2008 |
Hypertensive disease
|
0.430 |
Biomarker
|
group |
BEFREE |
Notch signaling thus provides a constitutive drive on expression of the major nitric oxide receptor (GUCY1A3/GUCY1B3) in arteries from mice, rats, and humans, and this control mechanism is disturbed in hypertension.
|
28465505 |
2017 |
Hypertensive disease
|
0.430 |
Biomarker
|
group |
HPO |
|
|
|
Coronary Arteriosclerosis
|
0.340 |
Biomarker
|
disease |
BEFREE |
GUCY1A3, encoding the α1 subunit, was identified as a risk gene for coronary artery disease and myocardial infarction, but its specific contribution to atherosclerosis remains unclear.
|
27315776 |
2016 |
Coronary Arteriosclerosis
|
0.340 |
Biomarker
|
disease |
CTD_human |
Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease.
|
22751097 |
2012 |
Malignant tumor of colon
|
0.300 |
Biomarker
|
disease |
CTD_human |
Global gene expression analysis of rat colon cancers induced by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
|
15059925 |
2004 |
Colonic Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Global gene expression analysis of rat colon cancers induced by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
|
15059925 |
2004 |
Adenoid Cystic Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma.
|
16762588 |
2006 |
Salivary Gland Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma.
|
16762588 |
2006 |
Thrombosis
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
|
24213632 |
2013 |
Thrombus
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
|
24213632 |
2013 |
Malignant neoplasm of salivary gland
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma.
|
16762588 |
2006 |
High altitude pulmonary edema
|
0.300 |
Biomarker
|
disease |
CTD_human |
α1-A680T variant in GUCY1A3 as a candidate conferring protection from pulmonary hypertension among Kyrgyz highlanders.
|
25373139 |
2014 |
High altitude pulmonary hypertension
|
0.300 |
Biomarker
|
disease |
CTD_human |
α1-A680T variant in GUCY1A3 as a candidate conferring protection from pulmonary hypertension among Kyrgyz highlanders.
|
25373139 |
2014 |
MOYAMOYA 6 WITH ACHALASIA
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension.
|
26777256 |
2016 |
Glaucoma, Primary Open Angle
|
0.200 |
Biomarker
|
disease |
MGD |
Soluble guanylate cyclase α1-deficient mice: a novel murine model for primary open angle glaucoma.
|
23527308 |
2013 |